The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 10
- 10 new
- Median first-year cost
- $395,794
- $4,016,638 in all
- Institutions
- 10
- 10 contact PIs
- Patents
- 1
- from 1 funded project
Awards by fiscal year
Fiscal years 2014 to 2026.
Most frequent institutions
- BAYLOR COLLEGE OF MEDICINE1
- CEDARS-SINAI MEDICAL CENTER1
- INDIANA UNIVERSITY INDIANAPOLIS1
- KAISER FOUNDATION RESEARCH INSTITUTE1
- MAYO CLINIC ROCHESTER1
and 5 other institutions
Most frequent study sections
- Special Emphasis Panel (ZDK1 GRB-8 (O1))10
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2015 | The Ohio State University Pancreatic Disorders Network (OSU-PDN)1U01DK108327-01 | Banks, Pamela G.Bellin, Melena D.Conwell, Darwin LewisGariepy, Cheryl EGelrud, AndresGress, Francis GHart, Philip A.Palermo, JosephSteen, HannoTopazian, Mark DWhitcomb, David Clement | OHIO STATE UNIVERSITY, OH | First-year cost $494,029 | Study section ZDK1 |
| FY2015 | INSPPIRE to Study Pediatric Chronic Pancreatitis1U01DK108334-01 | Uc, Aliye | UNIVERSITY OF IOWA, IA | First-year cost $480,136 | Study section ZDK1 |
| FY2015 | Pathophysiology, Epidemiology, and Prevention of Pancreatogenic Diabetes1U01DK108314-01 | Goodarzi, MarkPandol, Stephen J. | CEDARS-SINAI MEDICAL CENTER, CA | First-year cost $433,830 | Study section ZDK1 |
| FY2015 | The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer1U01DK108288-01 | Chari, Suresh T.Topazian, Mark D | MAYO CLINIC ROCHESTER, MN | First-year cost $397,500 | Study section ZDK1 |
| FY2015 | ALTERED MICROBIOME IN PANCREATITIS, DIABETES AND PANCREATIC CANCER1U01DK108326-01 | Fisher, William E | BAYLOR COLLEGE OF MEDICINE, TX | First-year cost $396,261 | Study section ZDK1 |
| FY2015 | Chronic Pancreatitis, Diabetes and Pancreatic Cancer: A Prospective Approach1U01DK108332-01 | Van Den Eeden, Stephen K. | KAISER FOUNDATION RESEARCH INSTITUTE, CA | First-year cost $395,327 | Study section ZDK1 |
| FY2015 | A Clinical Center to Study Immunological and Hormonal Biomarkers for the Diagnosis, Prediction and Treatment of Chronic Pancreatitis and its associated development to Diabetes and Pancreas Cancer1U01DK108300-01 | Habtezion, AidaKim, Seung KPark, Walter Gwang-Up | STANFORD UNIVERSITY, CA | First-year cost $394,220 | Study section ZDK1 |
| FY2015 | Consortium for the Study of Pancreatitis: Pittsburgh Clinical Center1U01DK108306-01 | Whitcomb, David Clement | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | First-year cost $380,000 | Study section ZDK1 |
| FY2015 | U01-Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Clinical Centers1U01DK108320-01 | Cusi, KennethForsmark, Christopher EHughes, Steven J | UNIVERSITY OF FLORIDA, FL | First-year cost $357,680 | Study section ZDK1 |
| FY2015 | Indiana University (IU) Clinical Center for Chronic Pancreatitis Clinical Research Network1U01DK108323-01 | Fogel, Evan L | INDIANA UNIVERSITY INDIANAPOLIS, IN | First-year cost $287,655 | Study section ZDK1 |
Patents from its funded projects
1 patent names 1 of the 10 funded projects.
- US 12,416,636 (opens the patent at USPTO, a PDF, in a new tab)PERSONALIZED TREATMENT OF PANCREATIC CANCERGranted September 16, 2025 to University of Florida Research Foundation, Inc.U01DK108320 · UNIVERSITY OF FLORIDA, FL
Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.
Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-14-0.3.3. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.